EPAS1 and renal cell carcinoma: Additionally, it enhances RCC growth and metastasis by activating the HIF2α/VEGF/MMP9/CCND1 signaling pathway in VHL mutant SW-839 and OSRC-2 cells (Chen et al., 2015).